Skip to content
VuFind
    • English
    • Español
  • Todo
  • Libros
  • eBooks
  • Revistas
  • Tesis
  • Audiovisual
  • EBSCO
  • Búsqueda Combinada
Advanced
  • A phase 2 study of botensilima...
  • Cite this
  • Text this
  • Print
  • Export Record
    • Export to RefWorks
    • Export to EndNoteWeb
    • Export to EndNote
  • Permanent link
Cover Image
QR Code

A phase 2 study of botensilimab and AGEN1423, an anti-CD73-TGFβ-trap bifunctional antibody, in subjects with advanced pancreatic cancer.

Bibliographic Details
Published in:Journal of Clinical Oncology Vol. 44; pp. 702 - 847
Main Authors: Berg, Julia, Bullock, Andrea J., Whooley, Peter D., Peters, Mary Linton Bounetheau, Horick, Nora K., Zerillo, Jessica Ann, Rattani, Ahmed Anwer Ali, Schlechter, Benjamin L., Sinanovic, Selma, Martin, Jane, Montgomery, Casey, Eaton, Elizabeth, Vyas, Monika, Muranen, Taru E., Hidalgo, Manuel, Bockorny, Bruno
Format: Journal Article
Published: American Society of Clinical Oncology 2026 Supplsmsnr 2
Online Access:View this record in EBSCOhost
  • Holdings
  • Description
  • Preview
  • Similar Items
  • Staff View

Search Options

  • Search History
  • Advanced Search

Find More

  • Browse the Catalog
  • Browse Alphabetically
  • Explore Channels
  • Course Reserves
  • New Items

Need Help?

  • Search Tips
  • Ask a Librarian
  • Cookie Settings